Vickerman & Driscoll Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$2M Buy
9,874
+2,351
+31% +$514K 1.23% 25
2019
Q4
$1.81M Sell
7,523
-748
-9% -$165K 0.92% 32
2019
Q3
$1.6M Hold
8,271
0.88% 38
2019
Q2
$1.52M Sell
8,271
-15
-0.2% -$2.69K 0.84% 41
2019
Q1
$1.57M Sell
8,286
-225
-3% -$43K 0.89% 37
2018
Q4
$1.66M Buy
8,511
+252
+3% +$49.2K 1.29% 23
2018
Q3
$1.71M Sell
8,259
-387
-4% -$76.3K 1.19% 23
2018
Q2
$1.6M Sell
8,646
-45
-0.5% -$7.96K 1.16% 24
2018
Q1
$1.48M Buy
8,691
+413
+5% +$75.8K 1.09% 26
2017
Q4
$1.44M Buy
+8,278
New +$1.46M 1.13% 22

Other funds holding AMGN

Vickerman & Driscoll Financial Advisors's AMGN Position: Q1 2020 in Review

Vickerman & Driscoll Financial Advisors increased its Amgen (AMGN) stake by 31% in Q1 2020, buying an estimated $514K and bringing the position to 9,874 shares worth $2M. The position accounts for 1.23% of the portfolio, ranked #25.

Vickerman & Driscoll Financial Advisors first reported a position in AMGN in Q4 2017 and has held it in 10 quarters since. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Vickerman & Driscoll Financial Advisors held 9,874 shares of Amgen worth $2M as of Q1 2020.
  • Vickerman & Driscoll Financial Advisors bought 2,351 Amgen shares in Q1 2020, an estimated $514K.
  • Amgen made up 1.23% of Vickerman & Driscoll Financial Advisors's portfolio in Q1 2020, its #25 holding.
  • Vickerman & Driscoll Financial Advisors first reported a position in Amgen in Q4 2017 and has held it in 10 quarters since.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Vickerman & Driscoll Financial Advisors's 13F filing for Q1 2020, filed 13 May 2020.